Chandra Bhagat Pharma Statistics
Total Valuation
BOM:542934 has a market cap or net worth of INR 376.50 million. The enterprise value is 493.78 million.
| Market Cap | 376.50M |
| Enterprise Value | 493.78M |
Important Dates
The next estimated earnings date is Friday, August 28, 2026.
| Earnings Date | Aug 28, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
BOM:542934 has 7.55 million shares outstanding.
| Current Share Class | 7.55M |
| Shares Outstanding | 7.55M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | +1.60% |
| Owned by Insiders (%) | 73.76% |
| Owned by Institutions (%) | 6.22% |
| Float | 1.30M |
Valuation Ratios
The trailing PE ratio is 12.36.
| PE Ratio | 12.36 |
| Forward PE | n/a |
| PS Ratio | 0.32 |
| PB Ratio | 1.14 |
| P/TBV Ratio | 1.14 |
| P/FCF Ratio | 4.53 |
| P/OCF Ratio | 4.08 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 10.42, with an EV/FCF ratio of 5.94.
| EV / Earnings | 16.21 |
| EV / Sales | 0.42 |
| EV / EBITDA | 10.42 |
| EV / EBIT | 13.31 |
| EV / FCF | 5.94 |
Financial Position
The company has a current ratio of 1.50, with a Debt / Equity ratio of 0.50.
| Current Ratio | 1.50 |
| Quick Ratio | 1.02 |
| Debt / Equity | 0.50 |
| Debt / EBITDA | 3.48 |
| Debt / FCF | 1.99 |
| Interest Coverage | 1.98 |
Financial Efficiency
Return on equity (ROE) is 9.66% and return on invested capital (ROIC) is 5.92%.
| Return on Equity (ROE) | 9.66% |
| Return on Assets (ROA) | 2.37% |
| Return on Invested Capital (ROIC) | 5.92% |
| Return on Capital Employed (ROCE) | 10.38% |
| Weighted Average Cost of Capital (WACC) | 5.78% |
| Revenue Per Employee | 25.95M |
| Profits Per Employee | 676,911 |
| Employee Count | 45 |
| Asset Turnover | 1.19 |
| Inventory Turnover | 34.93 |
Taxes
In the past 12 months, BOM:542934 has paid 12.11 million in taxes.
| Income Tax | 12.11M |
| Effective Tax Rate | 28.45% |
Stock Price Statistics
The stock price has decreased by -9.27% in the last 52 weeks. The beta is 0.09, so BOM:542934's price volatility has been lower than the market average.
| Beta (5Y) | 0.09 |
| 52-Week Price Change | -9.27% |
| 50-Day Moving Average | 39.13 |
| 200-Day Moving Average | 51.52 |
| Relative Strength Index (RSI) | 69.73 |
| Average Volume (20 Days) | 4,900 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, BOM:542934 had revenue of INR 1.17 billion and earned 30.46 million in profits. Earnings per share was 4.04.
| Revenue | 1.17B |
| Gross Profit | 230.86M |
| Operating Income | 37.09M |
| Pretax Income | 42.57M |
| Net Income | 30.46M |
| EBITDA | 47.39M |
| EBIT | 37.09M |
| Earnings Per Share (EPS) | 4.04 |
Balance Sheet
The company has 47.79 million in cash and 165.07 million in debt, with a net cash position of -117.28 million or -15.54 per share.
| Cash & Cash Equivalents | 47.79M |
| Total Debt | 165.07M |
| Net Cash | -117.28M |
| Net Cash Per Share | -15.54 |
| Equity (Book Value) | 331.27M |
| Book Value Per Share | 43.90 |
| Working Capital | 291.87M |
Cash Flow
In the last 12 months, operating cash flow was 92.36 million and capital expenditures -9.21 million, giving a free cash flow of 83.15 million.
| Operating Cash Flow | 92.36M |
| Capital Expenditures | -9.21M |
| Depreciation & Amortization | 10.30M |
| Net Borrowing | -43.53M |
| Free Cash Flow | 83.15M |
| FCF Per Share | 11.02 |
Margins
Gross margin is 19.77%, with operating and profit margins of 3.18% and 2.61%.
| Gross Margin | 19.77% |
| Operating Margin | 3.18% |
| Pretax Margin | 3.65% |
| Profit Margin | 2.61% |
| EBITDA Margin | 4.06% |
| EBIT Margin | 3.18% |
| FCF Margin | 7.12% |
Dividends & Yields
BOM:542934 does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | n/a |
| Shareholder Yield | n/a |
| Earnings Yield | 8.09% |
| FCF Yield | 22.09% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
BOM:542934 has an Altman Z-Score of 2.27 and a Piotroski F-Score of 7. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.27 |
| Piotroski F-Score | 7 |